|
|
||||||||
2-Microglobulin Substitution Affects Functional Binding of MHC Class I Molecules by CD8+ T Cells1
* Department of Immunology, University of Toronto, Toronto, Ontario, Canada; and
Department of Pathology and Laboratory Medicine, British Columbias Childrens Hospital and University of British Columbia, Vancouver, British Columbia, Canada
NK cells and CD8+ T cells bind MHC-I molecules using distinct topological interactions. Specifically, murine NK inhibitory receptors bind MHC-I molecules at both the MHC-I H chain regions and
2-microglobulin (
2m) while TCR engages MHC-I molecules at a region defined solely by the class I H chain and bound peptide. As such, alterations in
2m are not predicted to influence functional recognition of MHC-I by TCR. We have tested this hypothesis by assessing the capability of xenogeneic
2m to modify the interaction between TCR and MHC-I. Using a human
2m-transgenic C57BL/6 mouse model, we show that human
2m supports formation and expression of H-2Kb and peptide:H-2Kb complexes at levels nearly equivalent to those in wild-type mice. Despite this finding, the frequencies of CD8+ single-positive thymocytes in the thymus and mature CD8+ T cells in the periphery were significantly reduced and the TCR V
repertoire of peripheral CD8+ T cells was skewed in the human
2m-transgenic mice. Furthermore, the ability of mouse
2m-restricted CTL to functionally recognize human
2m+ target cells was diminished compared with their ability to recognize mouse
2m+ target cells. Finally, we provide evidence that this effect is achieved through subtle conformational changes occurring in the distal, peptide-binding region of the MHC-I molecule. Our results indicate that alterations in
2m influence the ability of TCR to engage MHC-I during normal T cell physiology.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 R.T. is a Michael Smith Senior Scientist and is funded by the Canadian Institutes of Health Research.
2 Address correspondence and reprint requests to Dr. Rusung Tan, Department of Pathology and Laboratory Medicine, British Columbias Childrens Hospital, 4480 Oak Street, Vancouver, British Columbia, Canada. E-mail address: roo{at}interchange.ubc.ca
3 Abbreviations used in this paper: MHC-I, MHC class I;
2m,
2-microglobulin; h, human; m, mouse; MFI, mean fluorescence intensity; DP, double positive; DN, double negative; SP, single positive; LN, lymph node; ES, embryonic stem cell; Tg, transgenic.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |